Selank and semax as potential hepatoprotectors in medical treatment of tuberculosis

• Main Authors: Alexey K. Petrovsky (Author), Nikolay A. Smirnov (Author), Vladimir P. Vdovichenko (Author), Tatiana B. Fedorova (Author), Edgar E. Kerbenev (Author), Vladimir N. Fedorov (Author)
• Format: Book
• Published: Belgorod National Research University, 2019-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Drug-induced hepatitis is common in clinical practice. This problem is particularly relevant in the treatment of tuberculous infection, because for this purpose, up to 5-6 hepatotoxic drugs are used simultaneously for a long time, which often (in 15-20% of cases) leads to medical liver...